Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis BXP

Max Ratio

Dividend Yield

5.75 %

5Y Dividend Growth

103.00 %

Consecutive Years

1 year

5Y Average Payout Ratio

26.00 %

Dividend History BXP

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 5.75 %
Consecutive Years 1
Forward Annual Dividend 2.41 GBX
Consistent Years 1
Dividend CAGR 3Y -6.20 %
Continuous Dividends
Dividend CAGR 5Y 15.17 %
Payout Ratio TTM
Dividend CAGR 10Y 16.26 %
Ex Dividend Date 11/22/2024

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth BXP

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin BXP

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income BXP

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM BXP

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio BXP

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Beximco Pharmaceuticals Limited BXP

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself BXP

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 4.22
Forward PE 3.39
Enterprise Value Revenue 1.17
Price Sales TTM 0.0050
Enterprise Value EBITDA 4.82
Price Book MRQ 0.56

Beximco Pharmaceuticals Limited Dividends: 5.75 % Yield, History, Payment Schedule

BXP
Current price
42.00 GBX +2.5 GBX (+6.33%)
Last closed 39.00 GBX
ISIN unknown
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange London Exchange
Capitalization 232 109 892 GBX
Yield for 12 month +16.67 %
1Y
3Y
5Y
10Y
15Y
BXP
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+27 203 284 873 GBX

Last Year

+24 062 707 720 GBX

Current Quarter

+7 537 199 037 GBX

Last Quarter

+7 178 276 274 GBX

Current Year

+12 031 756 042 GBX

Last Year

+10 480 288 297 GBX

Current Quarter

+3 413 586 790 GBX

Last Quarter

+3 314 101 999 GBX
EBITDA 10 497 311 189 GBX
Operating Margin TTM 19.51 %
Price to Earnings 4.22
Return On Assets TTM 7.62 %
PEG Ratio
Return On Equity TTM 12.45 %
Wall Street Target Price 11 092.61 GBX
Revenue TTM 46 302 264 389 GBX
Book Value 111.26 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 12.80 %
Dividend Yield 5.75 %
Gross Profit TTM 20 566 935 820 GBX
Earnings per share 0.090 GBX
Diluted Eps TTM 0.090 GBX
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY 27.60 %
Profit Margin 13.71 %

Technical Indicators BXP

For 52 Weeks

31.52 GBX 52.29 GBX
50 Day MA 42.60 GBX
Shares Short Prior Month
200 Day MA 40.60 GBX
Short Ratio
Shares Short
Short Percent